Bid Price | 44.00p | High Price | 45.00p |
---|
Ask Price | 45.00p | Low Price | 44.00p |
---|
Open Price | 43.50p | Spread | 2.22% |
---|
Prev Close | 43.50p | Volume | 123,042 |
---|
Arecor Therapeutics PLC Historic Prices
Date | Open | High | Low | Close | Volume |
---|
Jul 4, 2025 | 43.50 | 45.00 | 44.00 | 44.50 | 123,042 |
Jul 3, 2025 | 43.50 | 43.17 | 43.17 | 43.50 | 25,000 |
Jul 2, 2025 | 43.50 | 43.18 | 42.02 | 43.50 | 3,490 |
Jul 1, 2025 | 43.50 | 45.00 | 42.00 | 43.50 | 2,646 |
Jun 30, 2025 | 43.50 | 42.30 | 42.30 | 43.50 | 2,352 |
More Arecor Therapeutics PLC Historic Prices >Arecor Therapeutics PLC Information
Name | Arecor Therapeutics PLC | Index | FTSE AIM All Share |
---|
ISIN | GB00BMWLM973 | Epic | AREC |
---|
Type | Equity | Currency | GBX |
---|
Record Status | Active | Trading Segment | ASQ1 |
---|
Industry | Biotechnology | Sector | Healthcare |
---|
EMS | 1,000 | Trading Status | Closed |
---|
Shares in Issue | 37.76 m | Prev Close | 43.50p |
---|
PE Ratio | | Market Cap | £16.80 m |
---|
Div Yield | 0 | Div per Share | £NaN |
---|
EPS | -£0.16 | Div Cover | NaN |
---|
PEG | n/a | EPS Growth (%) | 0.00 |
---|
ROCE | -1.029449 | DPS Growth (%) | 0 |
---|
Current Ratio | 2.52887 | Quick Ratio | 1.882985 |
---|
Arecor Therapeutics PLC Director Deals
Declared | Type | Director | Pos. | Volume / Price | Value |
---|
21/05/25 | BUY | Andrew Richards | CH | 31,750 @ £0.47 | £14,913.00 |
21/05/25 | BUY | Sarah Howell | CEO | 21,077 @ £0.47 | £9,900.00 |
14/05/25 | BUY | Andrew Richards | CH | 35,000 @ £0.41 | £14,438.00 |
09/08/24 | PLAC | Alan Smith | RES | 22,222 @ £0.90 | £20,000.00 |
09/08/24 | PLAC | Andrew Richards | CH | 27,777 @ £0.90 | £24,999.00 |
09/08/24 | PLAC | Mohammad Fazeli | NED | 27,777 @ £0.90 | £24,999.00 |
09/08/24 | PLAC | Sarah Howell | CEO | 16,666 @ £0.90 | £14,999.00 |
08/11/22 | EXR | Sarah Howell | CEO | 20,666 @ £0.01 | £207.00 |
08/11/22 | EXR | Susan Lowther | RES | 62,000 @ £0.01 | £620.00 |
04/08/22 | PLAC | Christine Soden | NED | 6,667 @ £3.00 | £20,001.00 |
More Arecor Therapeutics PLC Director Deals >Arecor Therapeutics PLC News